✦ LIBER ✦

Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal

✍ Scribed by Quanrongzi Wang; Tongfu Yu; Yifeng Yuan; Haiwen Zhuang; Zhaojing Wang; Xisheng Liu; Min Feng

Book ID: 118763399
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 326 KB
Volume: 107
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.23227

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib reduces the percentage of tumo

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients

✍ Ingrid M.E. Desar; J. (Hans) F.M. Jacobs; Christina A. Hulsbergen-vandeKaa; Wim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

## Abstract Tyrosine kinase inhibitors (TKIs) as sorafenib are known to reduce the number of immunosuppressive regulatory T cells (Tregs) in the peripheral blood and thereby shifting the immune balance to a more stimulating setting. The effect of sorafenib on intratumoural Tregs is unclear but impo

Immune modulation of effector CD4+ and r

Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma

✍ Cabrera, Roniel; Ararat, Miguel; Xu, Yiling; Brusko, Todd; Wasserfall, Clive; At 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 600 KB

Regulatory T cells in chronic hepatitis

Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses

✍ H. H. Zhang; M. H. Mei; R. Fei; F. Liu; J. H. Wang; W. J. Liao; L. L. Qin; L. We 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB